z-logo
open-access-imgOpen Access
Immunologic treatment strategies in mantle cell lymphoma: checkpoint inhibitors, chimeric antigen receptor (CAR) T-cells, and bispecific T-cell engager (BiTE) molecules
Author(s) -
Joshua C. Pritchett,
Stephen M. Ansell
Publication year - 2019
Publication title -
annals of lymphoma
Language(s) - English
Resource type - Journals
ISSN - 2616-2695
DOI - 10.21037/aol.2019.05.01
Subject(s) - chimeric antigen receptor , mantle cell lymphoma , cancer research , cytotoxic t cell , medicine , antigen , lymphoma , t cell , immune checkpoint , immunology , immunotherapy , immune system , biology , in vitro , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom